share_log

Fusion Pharmaceuticals, BWXT Medical Announce Actinium-225 Partnership To Scale Supply For Developing Targeted Alpha Therapies

Fusion Pharmaceuticals, BWXT Medical Announce Actinium-225 Partnership To Scale Supply For Developing Targeted Alpha Therapies

Fusion PharmPharmticals和BWXT Medical宣佈建立Actdium-225合作夥伴關係,為開發靶向阿爾法療法擴大供應
Benzinga Real-time News ·  2023/01/05 17:04

Fusion Pharmaceuticals, BWXT Medical Announce Actinium-225 Partnership To Scale Supply For Developing Targeted Alpha Therapies

Fusion PharmPharmticals和BWXT Medical宣佈建立Actdium-225合作夥伴關係,為開發靶向阿爾法療法擴大供應

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論